Allspring Global Investments Holdings, LLC Sorrento Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$0.74 - $1.83 $738 - $1,826
-998 Reduced 2.14%
45,632 $40.4 Million
Q3 2022

Oct 26, 2022
BUY
$1.51 - $2.88 $70,402 - $134,277
46,624 Added 777066.69%
46,630 $73,000
Q2 2022

Jul 25, 2022
SELL
$1.24 - $2.33 $231,050 - $434,151
-186,331 Reduced 100.0%
6 $0
Q1 2022

May 02, 2022
SELL
$2.0 - $4.9 $31,910 - $78,179
-15,955 Reduced 7.89%
186,337 $434,000
Q4 2021

Jan 28, 2022
BUY
$4.65 - $7.23 $940,657 - $1.46 Million
202,292 New
202,292 $940,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.53M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email